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background: Micronutrient deﬁciencies have been associated with signiﬁcantly high reproductive risks, ranging from infertility to fetal
structural defects and long-term diseases. In this review we focus on the reproductive risks related to some micronutrients during the peri-
conceptional period, a critical step in determining fetal development and health due to the potential onset of several disorders.
methods: Embase Medline and PubMed databases, Google-indexed scientiﬁc literature and periodics from on-line University of Milan
Bibliotecary Service were searched to identify relevant publications. In vivo human studies were mainly searched for, but when needed
animal studies as well as in vitro and cell culture experiments were also considered.
results: Fertility, conception, implantation, fetal organogenesis and placentation are the critical stages potentially affected by nutrition during
the periconceptional period. Reactive oxygen species (ROS) and total homocysteine (tHcy) plasma levels are factors involved in the respective
mechanisms. The preconceptional period is particularly important since it affects both fertility and the early stages of gestation. Micronutrients’
dietary intake and maternal status affect the different phases of the onset and development of pregnancy as well as of the conceptus.
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conclusion: Although human studies are scarce, and conclusive evidence is provided solely for periconceptional folate and prevention of
neural tube defects (NTDs), the overall data indicate that micronutrients may affects fertility, embryogenesis and placentation, and the prophy-
lactic use of some micronutrients may be useful in preventing several adverse pregnancy outcomes. Efforts to increase awareness of a healthy
diet should be strengthened not only throughout pregnancy but also before. However, further researches in humans are necessary to optimise
periconceptional micronutrient requirements.
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Introduction
Diet is recognized as one of the major environmental factors inﬂuen-
cing the development of embryo and fetus, as well as maternal health
(Keen et al., 2003). Particularly, micronutrient deﬁciencies have been
associated with signiﬁcantly high reproductive risks, ranging from infer-
tility to fetal structural defects and long-term diseases (McArdle and
Ashworth, 1999; Ashworth and Antipatis, 2001; Black, 2001;
Andersen et al., 2006). There is evidence that indicates a role for
micronutrients supplementation in preventing some pregnancy dis-
orders (Ladipo, 2000; Bendich, 2001; Dı´az et al., 2003). Among
these, increasing calcium and magnesium intake can reduce the risk
of pregnancy-induced hypertensive disorders; ensuring adequate
intake of iron, zinc, iodine, calcium and folic acid during pregnancy
can improve pregnancy outcomes; increasing the intake of folic acid
before pregnancy can reduce birth defects; increasing folic acid and
vitamin B12 may reduce megaloblastic anaemia in mothers; providing
zinc supplements during pregnancy can improve birthweight and
reduce prematurity. Moreover, since micronutrients such as vitamin
A, iron and zinc are also involved in the function of the immune
system, their deﬁciency can lead to potentially harmful infections,
and enhancing vitamin A intake may reduce maternal mortality
(West et al., 1999). Furthermore, improved maternal intake of many
nutrients directly enhances the quality of breast milk (Picciano,
2003; Allen, 2005). However, the biological mechanisms responsible
for these association are not completely clear.
Since pregnancy is characterized by different stages that represent a
continuum, the timing of a nutritional insult impacts differently both on
the overall outcome of pregnancy and on the nature of adult diseases
by programming the post-natal pathophysiology, and having the poten-
tial to affect cell numbers or differentiation in the developing embryo
(Newnham et al., 2002; Fleming et al., 2004; Rhind, 2004; Buckley
et al., 2005; De Boo and Harding, 2006). Each stage in embryonic
and fetal development is indeed strongly inﬂuenced by maternal nutri-
ents and hormones (Ashworth and Antipatis, 2001; Sacks, 2004;
Gluckman et al., 2008), and the placental–maternal—fetal somatotro-
pic axes are fundamental in modulating this interaction (Gluckman and
Pinal, 2002). As Bloomﬁeld et al. (2004) demonstrated, periconcep-
tional undernutrition in sheep from 60 day before to 30 day after
mating alters the development of the fetal hypothalamic-pituitary-
adrenal axes (HPAA) inducing accelerated maturation many months
later, suggesting that events around the time of conception strongly
affect fetal development in late gestation. The authors found signiﬁ-
cantly higher baseline cortisol levels and a signiﬁcant positive associ-
ation between plasma cortisol and adrenocorticotropic hormone
concentration in fetuses by undernourished ewes compared with con-
trols. In addition, Edwards and McMillen (2002) demonstrated that the
detrimental effect on fetal HPAA of the maternal nutrient-restriction
before and in the ﬁrst week of gestation was not reversed by provision
of a maintenance diet from the second week of pregnancy. Similarly,
nutrient restriction of ewes, during perimplantation embryonic devel-
opment, programs long-term cardiovascular dysfunction in adult off-
spring (Gardner et al., 2004). Interestingly, a maternal low-protein
diet (LPD) in the ﬁrst days of dams’ pregnancy reduced cell number
in both the inner cell mass and the mid/late blastocyst, and reduced
insulin and essential amino acid levels in maternal serum, suggesting
that long-term programming of post-natal growth and physiology
(i.e. metabolic stress) may be induced irreversibly during the preim-
plantation period by maternal protein undernutrition through restric-
tion of early embryonic proliferation (Kwong et al., 2000). Similarly,
mouse embryo transfer experiments revealed a correlation between
maternal preimplantation LPD and offspring’s increased weight from
birth, hypertension and abnormal anxiety-related behavior, indicating
that increases in perinatal weight due to a maternal preimplantation
LPD was induced within blastocysts, with the visceral yolk sac endo-
derm as a proposed mediator (Watkins et al., 2008).
Moreover, in human pregnancies studies in the offspring of women
exposed to the Dutch Winter Famine showed that the nutrient
environment in the ﬁrst trimester of pregnancy was linked to increased
prevalence of coronary heart disease, raised lipids and obesity (Ravelli
et al., 1999; Roseboom et al., 2000, 2001), whereas famine occurring
during late gestation led to decreased glucose tolerance in adult life
(Ravelli et al., 1998).
In particular, the periconceptional period is critical in determining
fetal development and health. The onset of several malformations
and pregnancy related disorders (i.e. congenital abnormalities, fetal
loss, miscarriage, insufﬁcient fetal growth, premature birth and pre-
eclampsia) may indeed occur during this period (Steegers, 2005).
The present review aims to summarize the recent evidence about
the reproductive risk factors related to micronutrients during the peri-
conceptional period. Human in vivo studies were evaluated. The
majority of these are observational and retrospective, and deal with
energy and macronutrient intake. Data on the speciﬁc relationship
between individual micronutrients and reproductive outcomes are
often scarce, inconsistent or contradictory (Osrin et al., 2000; Shah
and Sachdev, 2004). Therefore, animal, in vitro and cell culture
studies were also considered to investigate the effects of micronutri-
ents during the different phases of the onset and development of preg-
nancy and development of the conceptus.
Methods
Embase Medline and PubMed databases (all publication years), Google-
indexed scientiﬁc literature as well as periodics from on-line University
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of Milan Bibliotecary Service were searched for all relevant articles written
in English. Search terms included micronutrient intake, micronutrient sup-
plements, micronutrient deﬁciency, periconceptional period, preconcep-
tional period, food intake, diet, embryogenesis, placentation, fetus
outcomes, maternal nutrition status, pregnancy outcomes, oxidative
stress (OS) and fertility. Human, animal, in vitro and cell culture exper-
iments were considered. Abstracts were critically evaluated to identify rel-
evant articles focusing on periconceptional critical stages potentially
affected by nutrition and effects of micronutrients’ intake and maternal
status during the different phases of the onset and development of preg-
nancy and conceptus. The reference lists of articles included in this review
were examined for additional potential articles and books were also
considered.
Role of speciﬁc dietary
micronutrients
Malnutrition is the state produced by an inadequate intake of a good
quality diet. This can mean intake of too few macronutrients, i.e.
undernutrition (protein-energy malnutrition and/or vitamin and
mineral deﬁciency), or of too many macronutrients, i.e. overnutrition
(obesity), or excessive amounts of inappropriate substances (alcohol-
ism). Interestingly, vitamin and mineral deﬁciency may occur in both
undernutrition (mainly an issue in developing and transitional
countries) and overnutrition (Young et al., 2004). For example, the
globalized high-energy and low-nutrient density Western dietary pat-
terns and trends, typiﬁed by snacking, breakfast skipping, fast foods,
soft drinks and convenience foods, are nutritionally unbalanced, and
intake of micronutrients in general fails to meet recommended daily
allowance (RDA) values (Nicklas et al., 2001; Paeratakul et al.,
2003; Drewnowski and Spencer, 2004; Cordain et al., 2005).
For this reason, micronutrient malnutrition represents an important
topic of public health worldwide, mainly in vulnerable population
groups such as infants, elderly, pregnant and lactating women. There
is sound evidence that adequate intake of micronutrients can
prevent many serious birth defects, reduce the risk of premature
and low birthweight (LBW) infants, and support maternal health.
Micronutrients seem to affect pregnancy outcomes through alterations
in maternal and fetal metabolism due to their role/involvement in
enzymes, signal transduction and transcription pathways and OS
(McArdle and Ashworth, 1999). Here, we deal with micronutrients
for which there is sufﬁcient information and major public health
concern; Table I shows their main functions.
Antioxidants
Complex antioxidant defenses are distributed within various cellular
compartments and in the external milieu; plasma contains a wide
range of substances with antioxidant properties.
Antioxidants are necessary for homeostasis; an imbalance in the
equilibrium of antioxidants and pro-oxidants can result in OS
damage, a key element in the pathogenesis of several diseases
(Agarwal et al., 2008), via effects on redox status and/or redox-
sensitive signaling pathways and gene expression (reviewed by Ruder
et al., 2008). By both direct and indirect contributions, antioxidants
enhance many aspects of the immune response (Bendich, 2001;
Arrigoni and De Tullio, 2002) and limit pathological aspects of the
cytokine-mediated response.
Antioxidants are present in both enzymatic (i.e. superoxide dismu-
tase (SOD), catalase, glutathione (GSH) peroxidase, and GSH
reductase) and non-enzymatic (i.e. vitamin C, vitamin E, selenium,
zinc, taurine, hypotaurine, GSH, b-carotene and carotene) forms
(Agarwal et al., 2008). Many antioxidants are obtained from the
diet, such as vitamin E and other tocopherols, vitamin C, b-carotene,
whereas proteins and peptides, such as glutathione, ceruloplasmin and
metallothionein, are synthesized endogenously (Grimble, 1998).
Vitamin E is a chain-breaking antioxidant that prevents the propagation
of free radical damage in biologic membranes, thus defending polyun-
satured fatty acid (PUFA) from auto-oxidation (Traber, 2006). Vitamin
C or L-ascorbic acid, present mainly in vegetables and fruit, exhibits a
protective effect against free-radical-induced oxidative damage by
acting as a reducing agent (Levine et al., 2006). It is also important
in the synthesis of collagen, carnitine, catecholamines. Other water-
soluble vitamins, such as vitamin B12, folic acid, vitamin B6, riboﬂavin,
are crucial for oxidative defense. Carotenoids and polyphenols are
potent antioxidants. Other micronutrients such as magnesium,
copper, zinc, manganese and selenium are involved in the antioxidant
defense as cofactors of enzymes (i.e. zinc in metallothionein, copper in
ceruloplasmin, copper–selenium–zinc in SOD, selenium in GSH per-
oxidase) (Fang et al., 2002).
Folate
Folate is widely distributed in foods (green-leafy vegetables, fruits,
liver, bread etc.). An inadequate dietary folate intake results in a
reduction of DNA biosynthesis and thereby of cell division, leading
to anemia, leucopenia and thrombocytopenia etc. (FAO/WHO
Report, 2004a). A decrease in the methylation cycle results in
elevation of plasma total homocysteine (tHcy), or hyperhomocystei-
nemia (HHCY). HHCY is implicated in the etiology of several diseases
such as arterial and/or venous thrombosis, vascular dementia by
demyelization, and certain neuropathies, such as sub-acute combined
degeneration of the spinal cord and peripheral nerves. In a
meta-analysis of randomized trials it was demonstrated that daily sup-
plementation with both 0.5–5 mg folic acid and about 0.5 mg vitamin
B12 would be expected to reduce blood homocysteine concentrations
by about a quarter to a third (Homocysteine Lowering Trialists’ Col-
laboration, 1998). Moreover, as an effective scavenger of oxidizing free
radicals, folic acid acts as antioxidant and can protect bio-constituents
such as cellular membranes or DNA from free radical damage (Joshi
et al., 2001).
Vitamin B12 or cobalamin
Bacteria and algae synthesize vitamin B12, and it enters the human
food chain through incorporation into food of animal origin such as
liver, milk, meat, oocytes (FAO/WHO Report, 2004b). Low vitamin
B12 levels are related to HHCY and high methylmalonic acid.
Anaemia, myelopathy and neuropathy are the main clinical manifes-
tations of vitamin B12 deﬁciency (Charmel, 2006). Intriguingly, the
Pune Maternal Nutrition Study showed that at 6 years old, children
born to mothers with low maternal vitamin B12 status at 18 weeks
of gestation and high folate status at 28 weeks were the most
insulin resistant (Yajnik et al., 2008). Moreover, higher maternal eryth-
rocyte folate concentrations at 28 weeks were associated with higher
fat mass and per cent body fat in the offspring. The authors speculated
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that vitamin B12 deﬁciency prevents the generation of methionine from
homocysteine by trapping folate as 5-methyltetrahydrofolate, and sub-
sequently reduces protein synthesis and lean tissue deposition. More-
over, the increased lipogenesis might be caused by the inhibition
of b-oxidation, owing to elevated concentrations of methylmalonic-
co-enzyme A. In fact, it can be hypothesized that imbalances of ade-
quate folate methyl donor and poor vitamin B12 cofactor lead to
further depletion of mitochondrial cobalamin stores, thereby to dys-
function of other B12-dependent reactions (Rosemberg, 2008). On
the whole, these results postulate that the defects in the one-carbon
metabolism plays a crucial role in intrauterine programming of adult
diseases.
Vitamin B6
Foods of animal origin are rich in vitamin B6; wholegrains and many
vegetables are also good sources. Deﬁciencies of vitamin B6 may
lead to HHCY (Mackey et al., 2006). Moreover, low plasma levels
of vitamin B6 are an independent risk factor for thrombosis (Saibeni
et al., 2003).
Vitamin A
Vitamin A can be obtained from food either as pre-formed vitamin A,
in the form of retinol or retinyl-esters which come from animal
sources, or as provitamin A form from plants, i.e. provitamin
A-carotenoids such as b-carotene. The highest concentration of
vitamin A is found in liver and ﬁsh liver oil. Yellow and green leafy veg-
etables provide provitamin A-carotenoids (Ross, 2006). Retinol is its
endogenous metabolite and retinoic acid (RA), a vitamin A derivative,
is a morphogenetically active compound. Vitamin A plays a key role in
vision and ocular retinoid metabolism as well as in cellular differen-
tiation (related to embryonic development and immunity). Caroten-
oids exert antioxidant properties. Vitamin A deﬁciency is linked to
xerophthalmia and Vitamin A-deﬁciency anemia whereas hypervitami-
nosis seems to be involved in teratogenesis, liver abnormalies and
bone mineral loss. Interestingly, it has been observed that in rodents
the control of neural patterning and differentiation are disrupted
when RA concentrations are lowered, whereas inappropriately high
concentrations of RA result in abnormal development of cerebellum
and hindbrain nuclei. Thereby, it has been supposed that even the
adult brain may be susceptible to an imbalance of RA, particularly
the hippocampus (McCaffery et al., 2003).
Iron
Nutritional sources of iron are meat, poultry, ﬁsh, cereals, bread and
green vegetables (FAO/WHO Report, 2004c). Worldwide, iron
deﬁciency represents the most common nutritional deﬁcit (Scholl,
2005), that can exist with or without anemia. Although iron deﬁciency
is a common cause of anemia, anemia may also result from other
causes (i.e. deﬁciencies of folate, vitamin B12 and vitamin B6).
Studies in both humans and animals have shown that iron-deﬁcient
anemia in early life is linked to altered behavioral and neural develop-
ment, and is suggested to result in irreversible effects on neurochem-
istry and neurobiology (reviewed by Beard, 2003, 2007). This may be
explained by considering alterations in morphology, neurochemistry
and biogenetics within the central nervous system. In fact, data on
human infants are consistent with altered myelination of white
matter, changes in monoamine metabolism in striatum and functioning
of the hippocampus (Beard, 2008).
Zinc
Zinc is abundantly present in meat, seafood, pulses, legumes and
whole-grain cereals (FAO/WHO Report, 2004d; King and Cousins,
2006). Zinc has antioxidant properties, by counteracting oxidation
through binding sulphydryl groups in proteins and by occupying
binding sites for iron and copper in lipids, proteins and DNA (Zago
and Oteiza, 2001). Evidence has been found for oxidative damage in
zinc-deﬁcient rats and mice (Oteiza et al., 1995), although zinc salts
have been shown to protect against oxidative damage and glutathione
depletion in mice (Bagchi et al., 1998). Moreover, zinc is present in the
brain, bound to proteins, and it is important for its structure and func-
tion (Bhatnagar and Taneja, 2001).
.............................................................................................................................................................................................
Table I Main functions of micronutrients involved in the periconceptional period
Micronutrient Function References
Folate Involvement in the DNA replication (cell cycle); methylation cycle (amino acids
cysteine and methionine cycle)
FAO/WHO Report (2004a), Scholl and Johnson
(2000)
Vitamin B12 Conversion of homocysteine to methionine as cofactor of the methionine synthase Ryan-Harshman and Aldoori (2008)
Vitamin B6 Metabolism of amino acids, lipids, one-carbon units and glycogen as co-enzyme;
pathways of gluconeogenesis, heme and neurotransmitter biosynthesis
Mackey et al. (2006)
Vitamin A Growth and differentiation of a number of cells and tissues Ross (2006)
Antioxidants Defence systems against free radical species Fang et al. (2002)
Iron Haematopoiesis; nucleic acid metabolism; carrier of oxygen to the tissues by red
blood cell haemoglobin; transport medium for electrons within cells; integrated part
of important enzyme systems
Cook et al. (1992); Beard (2003), FAO/WHO
Report (2004c), Wood and Ronnenberg (2006)
Zinc Structural, regulatory and catalytic functions as cofactor for numerous
metalloenzymes
McCall et al. (2000), Hambidge (2000)
Copper Neurotransmission, neuroropeptide maturation, oxidative phosphorylation, defence
from free radical damage as cofactor for numerous cuproenzymes and
copper-binding proteins
Turnlund (2006)
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Copper
The richest dietary sources of copper include shellﬁsh, nuts, seeds,
legumes, grains’ bran and germ, liver and organ meats. Copper exhi-
bits several biological roles being involved in connective tissues for-
mation, iron metabolism, cardiac function, immune function
(Turnlund, 2006) and central nervous system development (Prohaska,
2000; Gybina and Prohaska, 2003). Interestingly, new insights are
emerging into the role of iron and copper in neurocognitive and neu-
robehavioral development during the last two thirds of gestation, and
in long-term consequences of their perinatal deﬁciency (Beard et al.,
2003; Penland and Prohaska, 2004; Gybina and Prohaska, 2006;
Beard, 2008). Balances between copper and iron are recognized to
assure the proper brain development, as iron-deﬁciency results in
hypomyelination (Prohaska and Gybina, 2005) to suggest that iron
accumulation in rat brain during perinatal growth depends on ade-
quate copper nutrition of dams.
Critical stages and mechanisms
potentially affected by nutrition
in the periconceptional period
The periconceptional period consists of preconception, conception,
implantation, placentation and embryo- or organogenesis stages
(Fig. 1), and speciﬁc cellular events that occur during the distinct
stages of embryogenesis (Hirschi and Keen, 2000). Besides genetics,
each of these steps may be affected by maternal nutrition and, speciﬁ-
cally, by micronutrient imbalances (Finnell et al., 2004; Allen, 2005). In
particular, these may interfere with fetal organogenesis (embryogen-
esis) as well as with placentation.
Embryogenesis
The association between maternal folate status and fetal neural tube
defects (NTDs) is well recognized, as demonstrated by several inter-
ventional trials and observational studies (reviewed by de Bree et al.,
1997; Pitkin, 2007). Neural tube develops into the spine and NTDs
occur when the brain and skull and/or the spinal cord and the protec-
tive spinal column do not develop properly within the ﬁrst 4 weeks
after conception. Folate functions as a co-enzyme in single-carbon
transfers in the metabolism of aminoacids and nucleic acids. Moreover,
folate is the substrate donor in the remethylation of homocysteine into
methionine, catalyzed by methionine synthase and
5,10-methylenetetrahydrofolatereductase (MTHFR). Altered homo-
cysteine metabolism leading to HHCY has been proposed as the
mechanism involved in NTDs given that higher tHcy levels were
found in plasma or amniotic ﬂuid of NTD infants and their mothers
with respect to non-NTD individuals (Locksmith and Duff, 1998;
Tamura and Picciano, 2006). Moreover, HHCY depends on inherited
and acquired conditions (genetic polymorphisms of MTHFR 677
C!T and 1298 A!C); methionine synthase (MTR) 2756 C!G;
methionine synthase reductase (MTRR) 66 A!G) (Gue´ant et al.,
2003) and folate and/or vitamin B6/B12 deﬁciencies due to deregula-
tion of their normal metabolism and/or low dietary intake (Steen
et al., 1998).
Implantation and placentation
The process of implantation and placentation may also be affected by
maternal nutrition. Placental function is critical for nourishing the fetus
throughout pregnancy (Cross and Mickelson, 2006; Jansson and
Powell, 2006; Paﬁlis et al., 2007). Speciﬁcally, the placenta forms a
highly branched villous structure thus providing nutrients and oxygen
to the fetus (Cetin et al., 2005) to assure appropriate fetal growth
(Sparks et al., 1998). In particular, intrauterine growth restriction
(IUGR) is associated with a range of alterations in placental transport
functions, whereas accelerated fetal growth, in association with
maternal diabetes, is characterized by increased activity of placental
systems (Sacks, 2004; Cetin and Alvino, 2009). Nutrition may play a
role in altering the development of the placenta. In fact, despite an
initially normal growth trajectory, fetuses may have impaired growth
in the second part of gestation subsequent to nutrient deprivation
occurring early in gestation. Early in pregnancy the muscular maternal
spiral arteries are transformed to ﬁbrinoid lined vessels, and after
further invasion by endovascular cytotrophoblasts, these vessels
bath the chorionic villi in maternal blood bearing oxygen and nutrients
for fetal development. Defects in this process have been reported in
pregnancies complicated by IUGR (Sibley et al., 2005; Cetin and
Alvino, 2009). Proposed mechanisms include lowered number and
surface area of arterioles of tertiary villi, secondary vascular oblitera-
tion (Gagnon, 2003), increased susceptibility of trophoblasts to apop-
tosis by inﬂammatory cytokines or oxygen reduction (Crocker et al.,
2003). Also, impaired release of the vasoactive agents nitric oxide
(NO) and carbon monoxide by the invasive trophoblast cells seems
to be responsible for the reduction in spiral artery transformation
(Lyall, 2003).
Figure 1 Different pregnancy stages that represent a continuum,
from the preconceptional to the post-partum period.
Several and speciﬁcmalformations and pregnancy related disordersmay
originate during each phase. Preconception, conception, implantation,
placentation and embryo- or organogenesis are stages of the pericon-
ceptional period, which represents a critical step in determining fetus
development. From the nutritional point of view, ﬁrstly preconceptional
nutrition affects the overall health of childbearing-age women, thereby
their reproductive potential. Subsequently, periconceptional maternal
nutrition inﬂuences both the onset and the early stages of pregnancy,
affecting both maternal health and conceptus development throughout
the entire pregnancy. LMP: last menstrual period.
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Diabetes
Blastocyst development and subsequent implantation are affected by
high concentrations of D-glucose in diabetic mothers in a mouse
model (Leunda-Casi et al., 2001, 2002). This has also been demon-
strated in culturing rat embryos, as OS occurs in diabetes (Cedeberg
et al., 2001; Ornoy, 2007). Diabetes is associated with an imbalance
between pro-oxidant and antioxidant defenses in favor of
pro-oxidants, resulting in oxidative structural and functional modiﬁ-
cations of biomolecules. These modiﬁcations may result in secondary
trophoblast dysfunction (Jauniaux et al., 2006). Scavenging of free rad-
icals is achieved through enzymatic and non-enzymatic reactions.
Reactive oxygen species
Reactive oxygen species (ROS), reactive nitrogen species and reactive
chlorine species are produced in humans and animals under physio-
logical and pathological conditions (reviewed by Fang et al. 2002).
Free radicals play a key role in the origin of life and biological evolution,
such as signal transduction and gene transcription, regulating platelet
aggregation, leukocyte adhesion and angionesis, mediation of the
immune response. As oxidants and inhibitors of iron-sulfur center
enzymes, ROS cause oxidation of biomolecules such as DNA, lipids,
proteins, leading to cell injury and death (cytotoxic effect). Further-
more, ROS are involved in female reproduction, that is physiological
processes such as folliculogenesis, oocyte maturation, ovulation,
corpus luteum formation, endometrial cycle, luteolysis, implantation,
embryogenesis and pregnancy (reviewed by Taylor, 2001, Agarwal
et al., 2005, 2008). As demonstrated in embryo culture systems and
in pregnant animals with induced diabetes, ROS are suggested to be
involved in diabetic teratogenesis and to contribute to the prostaglan-
din imbalance, resulting from myoinositol and arachidonic pathways,
linking together potentially teratogenic mechanisms (Akazawa,
2005). In vitro, high glucose concentration impaired rat preimplantation
embryo development or induced degeneration of the embryos due to
apoptosis of blastocysts (Kos and Vogel, 2005) by suppression of
insulin and glucokinase expression, decreased mitochondrial function,
increased ROS formation and accelerated apoptosis, as well as to
activation of common stress signaling pathways, which could affect pro-
liferative, metabolic and neuroendocrine axes during later development
(Evans et al., 2002). Thus, imbalance in homeostatic control of ROS
exposure causes OS, which can affect fertilization and induce apoptosis,
resulting in embryo fragmentation, implantation failure or abortion
(Agarwal et al., 2008) or impair metabolic activity within embryos for
fetal and post-natal development. OS during embryogenesis and in
the placenta seems to be implicated in adverse pregnancy outcomes
such as birth defects, early pregnancy failure, miscarriage and pre-
eclampsia (Evers et al., 2004; Jauniaux et al., 2006; Agarwal et al.,
2005; Forges et al., 2007). Interestingly, NTDs in a mouse model of dia-
betic embryopathy have been demonstrated to be associated with
deﬁcient expression of Pax3, a gene required for neural tube closure,
and hyperglycemia-induced OS was responsible (Li et al., 2005).
Pre-eclampsia and IUGR
The pathogenesis of pre-eclampsia is established in the ﬁrst trimester
when an inadequate remodeling of the spiral arteries results in a
decreased perfusion of the placenta in the third trimester. OS and
inﬂammatory mediators are also involved in the abnormal implantation
associated with pre-eclampsia and IUGR. In fact, not only endothelial
dysfunction is causally important in the disorder but also alterations in
function predate clinically-evident pre-eclampsia, suggesting an inter-
action of reduced perfusion with maternal factors (Roberts et al.,
2003). Abnormal placentation leads in fact to placental ischemia,
resulting in generation of placental OS and increased levels of lipid per-
oxidation (reviewed by Agarwal et al., 2008). HHCY has been impli-
cated in adverse pregnancy outcomes such as placental abruption or
infarction and pre-eclampsia (Goddijn-Wessel et al., 1996; Tamura
and Picciano, 2006; Braekke et al., 2007). In this context, maternal
vitamin B6 status was observed to inﬂuence reproductive events
throughout the entire course of pregnancy (Ronnenberg et al.,
2007). The authors reported that this relationship was also found in
a case–control study (Wouters et al., 1993) demonstrating signiﬁ-
cantly lower plasma concentrations of vitamin B6 in women with his-
tories of recurrent spontaneous miscarriage compared with control
women. Furthermore, signiﬁcantly lower plasma vitamin B6 was
detected among women with placental abruption or infarction com-
pared with control women (Goddijn-Wessel et al., 1996). In addition,
some studies have documented associations between low vitamin B6
status and inﬂammatory responses (Friso et al., 2001; Saibeni et al.,
2003), and inﬂammation has been linked to early pregnancy loss
(Thellin and Heinen, 2003).
Inﬂuence of the preconceptional maternal
diet and health status
Preconceptional maternal nutrition plays a key role in reproductive health
(Allaire and Cefalo, 1998). This affects both fertility and the early stages of
gestation. Insufﬁcient energy stores may negatively affect ovulation,
menses and challenge the beginning of pregnancy. On the other hand,
excessive fat stores may inhibit conception by affecting ovulation
because of insensitivity to insulin, excess of male sex hormones and over-
production of leptin (The ESHRE Capri Workshop Group). It is also well
known that maternal overweight and obesity before conception increase
the risk of maternal complications during pregnancy such as gestational
hypertension, gestational diabetes, Cesarean delivery, macrosomia, as
well as birth defects such asNTDs, other neurological abnormalities, con-
genital heart disease, intestinal malformations and multiple congenital
anomalies (ADA, 2002;Watkins et al., 2003; Bartley et al., 2005;Catalano
and Ehrenberg, 2006; Oken, 2009).
Interestingly, theNurses’ Health Study II, a prospective cohort study of
more than 116,000 women aged 24–42 years, demonstrated that a high
‘fertility diet’ score was characterized by a lower intake of trans fat with a
simultaneous greater intake of mono-unsaturated fat, a lower intake of
animal protein with greater vegetable protein intake, a higher intake of
high-ﬁber and low glycemic carbohydrates, a greater preference for high
fat dairy products and a higher non-heme iron intake (Chavarro et al.,
2007a). In particular, the dietary trans unsaturated fats may increase the
risk of ovulatory infertility when consumed instead of carbohydrates or
unsaturated fats commonly found in non-hydrogenated vegetable oils
(Chavarro et al., 2007b) and replacing animal sources of protein with veg-
etable sources of protein may reduce the risk of infertility because of ano-
vulation (Chavarro et al., 2008). Signiﬁcantly higher preconceptional
dietary intakes of saturated fat was found in Dutch mothers of children
with outﬂow tract defects (OTD), compared with controls (Smedts
et al., 2008). In a case–control study, the use of the maternal Western
6 Cetin et al.
diet, e.g. high intakes of organ meat, red meat, processed meat, pizza,
legumes, potatoes, French fries, condiments, and mayonnaise but low
intakes of fruits, namely low ﬁber, iron, vitamins, antioxidants and
complex carbohydrate intakes and high amounts of saturated fatty acid,
protein, sugar and sodium, increased the risk of offspring with a cleft lip
or cleft palate approximately 2-fold compared with a Prudent diet, e.g.
high intakes of ﬁsh, garlic, nuts and vegetables (Vujkovic et al., 2007).
These factors are involved inOSand inﬂammationpathways triggering fer-
tility status. The pathological effects are exerted by various mechanisms
including lipid and DNA damage, inhibition of protein synthesis, and
depletionofATP (Agarwal et al., 2005).Nutrientsmodulate cytokinepro-
duction by inﬂuencing tissue concentrations of the molecules involved in
cytokine biology. Aberrant cytokine production is involved in athero-
sclerosis. The association of dietary fat intake with atherosclerosis has
been the subject of extensive studies. In particular, the intake of saturated
fat has been suggested to be positively associatedwith atherosclerosis and
coronary heart disease, and sources of saturated fat in the diet mainly
derived from animal sources and contain cholesterol. Cholesterol may
enhance cytokine production.
Infants of women with pregestational diabetes are reported to have
about 3-fold increased incidence of birth defects compared with those
of non-diabetic population (Shefﬁeld et al., 2002). Casele and Laifer
(1998) have shown that diabetic women frequently enter pregnancy
with poor glycemic control.
Some observational studies show an association between short
interpregnancy interval and increased risks of adverse outcomes prob-
ably due to maternal depletion of nutrients (Smith et al., 2003). As
suggested by Smits and Essed (2001), depletion of maternal folate
seems to be mainly involved, with particular regard to the risk of
fetal growth restriction (van Eijsden et al., 2008).
Another potential problem is that women of reproductive age and
pregnant women enter pregnancy without adequate iron reserves or
are already iron deﬁcient (Viteri and Berger, 2005; Milman, 2006). Pre-
conceptional anemia, particularly iron-deﬁciency anemia, was found to
be associated with reduced infant growth and increased risk of
adverse pregnancy outcomes (Scholl and Hediger, 1994; Ronnenberg
et al., 2004; Buckley et al., 2005). Plausibly, it may be supposed that
either anemia in the periconceptional period has an independent
effect on infant growth by inﬂuencing hormone synthesis (Allen,
2001) or the moderate preconceptional anemia turns to a more
severe anemia during pregnancy (Breymann, 2002) leading to the
observed growth deﬁcits. In a prospective observational study in
China, it was observed that the risk of preterm delivery and LBW
was increased more than 2-fold in moderately anemic women and
more than 3-fold in those with severe anemia during early pregnancy
(4–8 weeks) (Zhou et al., 1998).
Effects of periconceptional
micronutrients on pregnancy
outcomes
The preconceptional period
Preconceptional maternal nutritional status and diet impact on repro-
ductive health. Evidence on the preconceptional involvement of micro-
nutrients upon pregnancy outcomes in humans is reported in Table II.
Despite some dietary investigations that refer to periconceptional
period, data reﬂect the maternal nutrition status in the preconcep-
tional period.
Preconceptional folic acid supplementation is a goal of public health
to prevent NTDs (reviewed by Pitkin, 2007). A low iron status was
suggested to adversely affect important regulators of growth and
development in rats (Gambling et al., 2002). A relationship was
observed between low ferritin (,12 mg/l), a marker of depleted
iron stores, and reduced birthweight, as well as between elevated fer-
ritin (60 mg/l), a biomarker of acute or chronic inﬂammation, and
increased risk of LBW and fetal growth restriction (Ronnenberg
et al., 2004). An open question is whether iron supplementation,
which is generally started in the second half of pregnancy, could reduce
the rates of preterm LBW, or whether anemia plays a role in placental
development solely during early pregnancy and therefore must be pre-
vented prior to conception. Interestingly, prophylactic iron supplemen-
tation given from about 12 weeks of gestation to the third trimester
among low income women in a randomized controlled trial in North
Carolina evidenced that the birthweight was signiﬁcantly higher in the
supplemented groups than in controls (Siega-Riz et al., 2006).
Maternal vitamin B6 status was observed to inﬂuence reproductive
events from the start of pregnancy (Ronnenberg et al., 2007). Concei-
vably, the effects of poor prepregnancy maternal vitamin B6 status on
the early gestational events could be explained ﬁrstly through the
involvement of vitamin B6 dependent-co-enzymes in the metabolism
of amino acids, lipids, nucleic acids and glycogen. Then, by considering
the association between vitamin B6 deﬁciency and impairment of
enzymes involved in the structural integrity of arterial walls, it could
be supposed to affect implantation and early placental development.
Thereby, assessing hematological indices before conception should
be of great utility, as they are likely to reﬂect status in the periconcep-
tional period. On the contrary, biomarker concentrations assessed at
various times throughout pregnancy are affected by plasma volume
expansion, consequently the interpretation of the relation between
these measures and birth outcomes can be challenging (de Weerd
et al., 2003a).
Despite the paucity of studies dealing with preconceptional dietary
patterns, it is clear that there is a strong relation between imbalance of
micronutrients before conception and the successful onset, as well as
healthy development of pregnancy as listed below.
Fertility
Analysis of data from the Nurses’ Health Study II evidenced that the
consumption of iron supplements and non-heme iron from foods
may decrease the risk of ovulatory infertility (Chavarro et al., 2006).
Folate seems to be important for oocyte quality and maturation
(Ebisch et al., 2007). Zinc plays a role in ovulation and the menstrual
cycle. Oocyte maturation, ovulation, luteolysis and follicle atresia are
affected by ROS unbalance. OS and apoptosis are involved in follicu-
logenesis, follicular atresia and luteal regression. In particular, OS leads
to detrimental effects on second meiotic division progression, dimin-
ished gonadotrophin, antisteroidogenic actions, DNA damage and
inhibited protein ATP production (Ruder et al., 2008). For this
reason, a positive role of the antioxidant status may be explained by
counteracting ROS effects (Forges et al., 2007; Ruder et al., 2008).
Similarly, folate, zinc, ROS and thiols affect apoptosis, which is
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important for regulation of follicle atresia (Hussein, 2005), degener-
ation of the corpus luteum and endometrial shedding. The concen-
trations of these nutrients may therefore have substantial effects on
reproduction. Poor folate status and HHCY are mainly crucial due
to their involvement in cell division (e.g. of oogonia or of granulose
cells), inﬂammatory cytokine production, OS, apoptosis and defective
methylation reactions (Forges et al., 2007). In this context, DNA syn-
thesis is important for the development of oocytes, and several
enzymes involved in DNA synthesis are zinc- or vitamin B-dependent
(Ebisch et al., 2007). Deﬁciencies of vitamins A, C and D have been
demonstrated to result in diminished fertility in rats and rainbow
trout as reported by Ebisch et al. (2007). However, though addition
of vitamins C and E has been shown to strengthen antioxidant
defenses in in vitro media, oral antioxidant supplementation in
human studies does not provide deﬁnite, conclusive evidence.
Conception and implantation
The interaction of nutrients with the epigenetic system may lead to
variations associated with chromatin remodeling and regulation of
gene expression that underlie the developmental programming of
pathological consequences in adulthood (reviewed by Junien, 2006).
After fertilization, the genome of the zygote undergoes rapid
demethylation at coding sequences and at repetitive sequences.
After implantation, the embryonic ectoderm and mesoderm
genome is hypermethylated, through de novo methylation, whereas
the extra-embryonic cell genome, such as the primary endoderm
and trophoblast, remains hypomethylated. These processes might
be enhanced by methyl donors provided by the folate-methionine
pathway. In this context, experiments on mice and rats demonstrated
that methyl-supplements and zinc adequate diets during pregnancy
affected phenotypic modiﬁcations in offspring (Wolff et al., 1998;
Cooney et al., 2002; Prasolova et al., 2006; Maret and Sandstead,
2008). Interestingly, Sinclair et al. (2007) provided the ﬁrst clinical evi-
dence about the extent to which the periconceptional supply of folate,
vitamin B12 and methionine in mature female sheep affected epigenetic
alterations to DNA methylation and adult health-related phenotype in
offspring. The methyl-deﬁcient diet around the time of conception
resulted in signiﬁcant changes in the methionine cycles within
ovarian follicles of ewes, and led to adult offspring being heavier and
fatter, insulin-resistant, eliciting altered immune responses and with
elevated blood pressure. These clinical outcomes were associated
with modiﬁcation in methylation status of 4% of 1400 gene-associated
cytidine-guanosine (CpG) islands, mainly in male fetuses, to indicate
that periconceptional speciﬁc dietary inputs to the methionine cycles
may affect a signiﬁcant part of genome in offspring with long-terms
implications for adult health.
The involvement of one-carbon metabolism has been suggested in
genetic disorders such NTD. Signiﬁcantly, the MTHFR genotype has
been shown to alter homocysteine metabolism mainly when folate
.............................................................................................................................................................................................
Table II Human studies about the impact of preconceptional micronutrients on pregnancy outcomes
Reference Type of study Micronutrient Outcome Results
Groenen et al.
(2004)
Case control study. The
Netherlands. Food frequency
questionnaire
Preconceptional intake
of several vitamins and
minerals
Spina biﬁda Intakes of iron, magnesium and niacin are
associated with a 2- to 5-fold increased risk of
spina biﬁda
Velie et al. (1999) Population-based case–
control. California. A 98-item
food frequency questionnaire
Preconceptional
supplemental and
dietary zinc intake
NTDs Risk of NTDs in infants and fetuses decreased
with increasing maternal zinc intake
Krapels et al.
(2004a)
Case–control study. The
Netherlands. Food frequency
questionnaire
Preconceptional dietary
intake
OFC Increased intake of iron, magnesium, ascorbic
acid reduced the risk of offspring affected by
OFC
Smedts et al.
(2008)
Case control study. The
Netherlands.
Semiquantitative food
frequency questionnaire
Dietary intake of
riboﬂavin and
nicotinamide
OTD Dietary intakes of riboﬂavin and nicotinamide
were lower in mothers of a child with an OTD
than in controls (P, 0.05). Low dietary
intakes of both riboﬂavin (,1.20 mg/day)
and nicotinamide (,13.5 mg/day) increased
more than 2-fold the risk of a child with an
OTD
Verkleij-Hagoort
et al. (2006)
Case control study. The
Netherlands. Food frequency
questionnaire
Dietary intake of
B-vitamins
Congenital hearth defect
(CHD)
A diet low in vitamin B12 is associated with an
increased risk of a child with a CHD
Ronnenberg et al.
(2002)
Prospective case–control
study. China. Haematological
assessment
Preconception B
vitamin status
Preterm birth, LBW,
small-for-gestational-age
Risk of preterm birth was 60% lower among
women with vitamin B12 258 pmol/l than
among vitamin B12-deﬁcient women
(P, 0.05) and was 50% lower among women
with vitamin B6 30 nmol/l than among
vitamin B6-deﬁcient women
Ronnenberg et al.
(2007)
Prospective study. China.
Haematological assessment
Preconceptional B
vitamin status
Conception, early pregnancy
loss, clinical pregnancy
Poor vitamin B6 status decreased the
probability of conception and contributed to
the risk of early pregnancy loss in conceptive
cycles
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status is low, suggesting a genetic-nutrient interactive effect in disease
risk (Gue´ant et al., 2003). Similarly, it has therefore been suggested
that gene–nutrient interactions affecting one-carbon metabolism
may inﬂuence the chance/risk of survival and the risk of trisomy
(Wilson et al., 1999). Interestingly, notwithstanding weakly, poly-
morphisms of folate-related genes are reported to be associated
with the prevalence of placental abruption (reviewed by Tamura and
Picciano, 2006). Even retinoids represent an example of a gene–nutrient
interaction (reviewed by Finnell et al., 2004). This issue raised in 1969
when differential teratogenic responses to retinoids in three rat strains
were observed. Then, the large amount of data from several exper-
imental over the past two decades seems to indicate that the biologi-
cal activity of retinoids is mediated by a retinoid receptor superfamily
encoded by different genes and regulating cell proliferation and differ-
entiation (reviewed by Finnell et al., 2004). Namely, the expression of
receptors and the availability of retinoid compounds in the adequate
concentrations contribute to the normal homeostasis and develop-
ment of organism. Thereby, alteration in retinoids’ concentrations
interacting with the embryonic genotype can results in defects such
as congenital malformations.
Placentation
In a prospective study of 1650 pregnancies, low iron status early in
pregnant women was found to be inversely related to placental size
(Hindmarsh et al., 2000). An inverse relation between serum ferritin
concentration and overall measures of peripheral villous capillarization
was observed. The surface area of capillaries involved in gas exchange
in the mature intermediate and terminal villi was strongly and inversely
related to serum ferritin suggesting that anaemia inﬂuences the pattern
of placental vascularization.
The use of antioxidants seems to be useful to reduce the damage
on placenta, thereby the risk of pre-eclampsia because of its limited
antioxidant enzyme capacity in the ﬁrst trimester (Jauniaux et al.,
2004). In fact, given that the risk factors for pre-eclampsia are also
risk factors for atherosclerosis, other similarities can be suggested
(Grataco´s, 2000). OS has been hypothesized to be important in
altered endothelial function leading to atherosclerosis (Navab et al.,
2004). Consequently, it has been assumed that reduced placental per-
fusion generates free radicals generating systemic oxidative damage, as
supported by evidence of OS in the circulation and tissues of women
with pre-eclampsia (Roberts et al., 2003). Grataco´s et al. (1998) and
Jain and Wise (1995) conﬁrmed that serum lipid peroxide levels are
signiﬁcantly higher and serum vitamin E levels signiﬁcantly lower in
women with pre-eclampsia than in women with normal pregnancies.
In this regard, the reduction in maternal and placenta antioxidant
defense in pre-eclampsia is linked to an excessive depletion of antiox-
idants through the increased generation of oxygen free radicals
(Jauniaux et al., 2006). Moreover, abnormal placentation leads to
increased levels of placental lipid peroxidation, probably due to the
presence of NADPH oxidase in the placental syncytial microvillus
membrane, producing increased amounts of the superoxide radical
(reviewed by Agarwal et al., 2008). At present, nutrition has not
been assessed during the periconceptional period or during the
early pregnancy in women that later develop pre-eclampsia.
However, we may hypothesize that nutrients can affect OS by increas-
ing or decreasing free radicals or antioxidants or by providing
substrates for the formation of ROS. Moreover, they could modify
inﬂammatory response in the period when placentation occurs. In par-
ticular, adequate intake of vitamin C and E during the second trimester
of pregnancy is recognized to improve the biochemical incidence of
OS (Jauniaux et al., 2006). Similarly, the postulated involvement of
deﬁciencies of trace elements in pre-eclampsia relates to the fact
that they are present in metallothionein (zinc), ceruloplasmin
(copper), SOD (copper, selenium, zinc) and glutathione peroxides
(selenium). In addition, a potential beneﬁt of n-3 fatty acids in prevent-
ing pre-eclampsia has been suggested in a prospective cohort study
enrolling 1718 women (Oken et al., 2007). Theoretically, n-3 fatty
acids may alter prostanoids in favor of vasodilators eicosanoids. Inter-
estingly, lower n-3 fatty acid levels were demonstrated in erythrocytes
of women with pre-eclampsia (reviewed by Roberts et al., 2003).
Moreover, in an observational study in an Icelandic community with
traditional ﬁsh and cod liver oil consumption, an inverse association
was found between the proportion of long-chain n-3 PUFA in red
blood cells of women at the 11th to 15th week of pregnancy and pla-
cental weight (Magnusardottir et al., 2009).
Some ‘placenta events’ are postulated to arise from deﬁciencies of
either folate and/or vitamin B12 or defects within the methionine–
homocysteine metabolic pathways (Goddijin-Wessel et al., 1996;
Ray and Laskin, 1999). In this context, HHCY has been shown to
provoke vascular inﬂammation, to decrease the bioavailability of NO
that is an important endothelium vasodilatator, and seems to be
associated with the production of ROS (Forges et al., 2007). This
means that folate-deﬁciency or HHCY may underlie endothelian dys-
function, and therefore placental endovasculature (Ray and Laskin,
1999), a theory supported by the observation that elevated serum
homocysteine concentrations have been associated with an increased
risk of diseases, such as atherosclerotic, thromboembolic and neuro-
degenerative disorders (reviewed by Diaz-Arrastia, 2000; Kuo et al.,
2005; Folstein et al., 2007; Forges et al., 2007).
Embryogenesis
There is consistent scientiﬁc evidence that folic acid (the synthetic
form of the vitamin folate) is of critical importance both pre- and peri-
conceptionally in protecting against NTDs in the developing fetus
(MRC, 1991; Czeizel and Duda´s, 1992; Bendich, 2001; Moore et al.,
2003; Czeizel et al., 2004; Shah and Sachdev, 2004; Padmanabhan,
2006). In general, women are advised to take 0.4 mg/day when plan-
ning a pregnancy whereas they are recommended to take 4.0 mg/day
if they experienced a previous pregnancy affected by NTD (de Bree
et al., 1997; Geisel, 2003; Pitkin, 2007). Involved in DNA synthesis
and cell division, folic acid plays a vital role in fetal development. More-
over, low folate status seems to increase risk of preterm delivery,
LBW and fetal growth restriction as well as other fetal malformations
(Czeizel et al., 1999; Tamura and Picciano, 2006). Low B12 levels are
related to HHCY and high tHcy level is associated with NTDs (Mills
et al., 1995; Ray and Laskin, 1999; Ray and Blom, 2003) and CHDs
(Verkleij-Hagoort et al., 2008). Neural crest cells are involved not
only in the embryogenesis of the neural tube, lip and palate, but
also in cardiovascular development. The migration and differentiation
of neural crest cells is inﬂuenced by homocysteine, and vitamin B12 is
an important determinant in the homocysteine pathway, thereby con-
tributing to the embryogenesis of the heart in the ﬁrst weeks after
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conception (Verkleij-Hagoort et al., 2008). In a case–control study in
the Netherlands, it was observed that the periconceptional intake of
thiamine, niacin and pyridoxine (vitamin B6) seems to contribute to
the prevention of orofacial cleft (OFC) defects (Krapels et al.,
2004b). This result may be explained by considering vitamin B6 invol-
vement into the homocysteine pathway.
Regarding vitamin A, retinoids are thought to be involved in the
development of several embryonic systems (reviewed by Finnell
et al., 2004). In particular, several embryonic anomalies were observed
in vitamin A-deﬁcient quail embryos developing in the absence of RA
(Maden et al., 1996). Thus, RA plays a crucial role in central nervous
system development (Maiden et al., 1996), i.e. neural crest survival,
neuritis outgrowth and hindbrain patterning. Vitamin A and RA are
part of the normal regulatory system required. Nevertheless, exces-
sive intake (.10 000 IU/day) has been shown to be teratogenic in
animals (Williamson, 2006). Malformations were also seen in the
human embryo exposed to RA due to treatment of the mother
with the acne drug Accutane (13-cis RA) (reviewed by McCaffery
et al., 2003). However, other results are contrasting (Dolk et al.,
1999). In fact, although the overall recommendation is that vitamin
A or retinol intake below 3000 mg (10 000 IU)/day is safe, some
have argued that vitamin A intake up to 9000 mg (30 000 IU)/day rep-
resents harmless levels (Miller et al., 1998). In this context, in a
population-based case–control study carried out in Norway no evi-
dence of an increased risk of clefting was found with an intake of
total vitamin A or retinol of more than 3000 mg (10 000 IU) (Johansen
et al., 2008).
Animal models have shown that severe maternal zinc deﬁciency in
early pregnancy results in impaired implantation, abortions and fetal
malformations, including cleft lip and palate, brain and eye malfor-
mations, numerous abnormalities of the heart, lung and urogenital
systems (Keen et al., 2003). Biochemical and functional abnormalities
can occur as a result of a zinc deﬁcit (Maret and Sandstead, 2008).
Interestingly, Keen et al. (2003) reported that even transitory
periods of zinc deﬁciency (5–6 days) can be teratogenic in rodent
models, and 3 days of periconceptional zinc deﬁciency can adversely
affect embryonic development. The consideration that zinc deﬁciency
is a teratogenic risk in humans may be supported by the correlation of
low plasma zinc concentrations in the ﬁrst and third trimesters of preg-
nancy with an increased risk for malformations and LBW, respectively.
Zinc deﬁciency is thought to inﬂuence embryonic and fetal develop-
ment through reduced cell proliferation, or reduced protein synthesis
or reductions in rates of tubulin polymerization rather than increased
rates of cellular oxidative damage or increased rates of apoptosis and
reduced binding of hormones and transcription factors dependent on
zinc-ﬁnger regions (Jankowski-Hennig et al., 2000; Mackenzie et al.,
2002).
A copper deﬁciency-associated teratogenicity has been suggested
(Keen et al., 1998). Embryos obtained from copper-deﬁcient dams
and cultured for 48 h in either copper-adequate or copper-deﬁcient
serum displayed numerous abnormalities, such as swollen hindbrains,
blisters, blood pooling and distention of the large vessels (Hawk et al.,
1998). Since SOD activity was lowest in embryos cultured in copper-
deﬁcient serum, and antioxidant (copper–zinc-SOD or GSH peroxi-
dase) supplementation reduced the teratogenicity of the copper-
deﬁcient serum, it may be postulated that dysmorphology is due in
part to free radical induced damage occurring secondary to an
impaired oxidant defense system. Moreover, the copper-deﬁcient
embryos also had low cytochrome c oxidase activity compared with
control embryos suggesting that multiple factors contribute to
copper deﬁciency-induced abnormalities. Similar results were found
in ‘Xenopus laevis’ embryos from frogs administered a low-Cu diet
for 120 day (Fort et al., 2000). On the contrary, although an effect
of copper deﬁciency on the human conceptus has been suggested,
no causal relation between low fetal copper concentrations and mal-
formations has been demonstrated. In other words, it has not yet
been proven whether the effects of copper deﬁciency on the
embryo or fetus are due directly to a deﬁciency of the micronutrient,
or whether they indirectly occur through the copper deﬁciency-
modulated metabolism of the mother (for example as a consequence
of maternal anemia, production of pregnancy hormones or growth
factors etc.) (Keen et al., 1998).
In a study aimed to evaluate the effects of ethanol on fetal develop-
ment, ‘Xenopus laevis’ embryos were treated with ascorbic acid 2 h
prior to ethanol exposure, and then transferred to medium in the
presence or absence of 100 mM ethanol for 12 h. The
ethanol-induced ROS production and NF-kB activation were inhibited
and the ethanol-treated embryos were protected against microence-
phaly and growth retardation, suggesting a potential use of ascorbic
acid as an effective protective agent for human fetal alcohol syndrome
(Peng et al., 2005). Furthermore, antioxidative treatment of
streptozotocin-induced diabetic rats with vitamins E and C decreased
fetal malformation rate and diminished oxygen radical related tissue
damage (Cedeberg et al., 2001). A prophylactic effect of vitamin E
against diabetic embryopathy was also demonstrated by Sivan et al.
(1996). Inclusion of vitamin E in culture medium, which stimulates
development both before and after embryo transfer, was demon-
strated to suppress ROS damage in bovine embryos (Olson and
Seidel, 2000). On the whole, these data suggest that antioxidants
exert beneﬁcial effects on embryo development, possibly by a
reduction in the incidence of apoptosis (Agarwal et al., 2008). Simi-
larly, the use of a dietary PUFA that speciﬁcally increases arachidonic
levels signiﬁcantly reduced the incidence of diabetic embryopathy in
rats (Reece et al., 1996). A signiﬁcant reduction in the incidence of
maternal diabetes-related fetal malformations and IUGR has been
reported in diabetic rats also with the supplementation of lipoic acid
(Al Gaﬂi et al., 2004).
Conclusions
The achievement of a successful pregnancy represents one of the fun-
damental functions of existence. Although scant, data suggest a signiﬁ-
cant role of micronutrients in the periconceptional period. The
nutritional status of women must be a goal for preventing detrimental
nutritional unbalances. In particular, diet during the ﬁrst trimester may
be more important to development and differentiation of various
organs. Moreover, also preconceptional nutrition is crucial for an
optimal onset and development of pregnancy. Unfortunately, nutri-
tional intake of childbearing-age women appears to be inadequate
during the preconceptional period (de Weerd et al., 2003b; Mourati-
dou et al., 2006) mainly in terms of micronutrients, but also consider-
ing the global shift towards the Western diet (Popkin and
Gordon-Larsen, 2004). Thus, efforts to increase awareness of a
healthy diet and lifestyle should be strengthened not only throughout
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pregnancy but also before, given that pregnancies are often unplanned.
A meta-analysis evidenced the relationship between preconceptional
care and reduced risk of congenital anomalies in the offspring of
women with pregestational diabetes mellitus (Ray et al., 2001). More-
over, the role of preconceptional folic acid supplementation in the
prevention of NTDs has been documented. In this context, consider-
ing the relatively high frequencies of both the MTRR and the MTHFR
polymorphisms in the general population, maintenance of adequate
vitamin levels (cobalamin and folate) should be stressed for pregnancy
(Wilson et al., 1999).
However, conclusive evidence was provided solely for periconcep-
tional folate and prevention of NTDs, and prospective studies related
to the association between periconceptional maternal nutrition and
pregnancy outcomes are scarce. Interestingly, intakes of magnesium
and ascorbic acid above the RDA at 375.92502.9 and
97.92295.8 mg/day, respectively, were found to substantially
decrease OFC risk (Krapels et al., 2004a). By considering that RDAs
for pregnant women are 300–360 mg/day magnesium and 90 mg/
day ascorbic acid, these results seem to indicate that the RDAs for
these nutrients are insufﬁcient for women of reproductive age. More-
over, although the majority of data indicate that vitamin A intake
above 3000 mg/day should be avoided in the periconceptional
period, this has been recently discussed (Miller et al., 1998; Johansen
et al., 2008), and similarly, there is disagreement on the need for iron
prophylaxis early in pregnancy.
In particular, causes or at least potential mechanisms between
micronutrient status in the periconceptional period and pregnancy
outcomes remain still to be well-deﬁned/understood. Speciﬁcally,
the timing of the potential insults need to be studied in depth both
in vitro and in animal models. Moreover, there is a dramatic need
for further experimental and interventional human studies, in order
to optimize dietary recommendation and thus maternal periconcep-
tional nutritional status.
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